IMUGENE CHART. TA only, page-4444

I don't think it's anything we haven't already seen. For months there had been early results from HERVaxx (1b) which apparently aroused little interest in many shareholders, the significance of these results was striking for those that knew where the standard was set. It was around this time that I piled in every last dollar I could find all whilst wondering why everyone else wasn't doing the same.

I suspect that critical data or indications have already been placed in our lap, if you know then you know, if you don't then you'll keep asking when dinner is while everyone else is moving onto dessert.

My average is under 6c and I still haven't sold a single share.